0.80 USD
▼-0.02-2.12%
盘后 0.80 0.00%
2026-11-20
市值
$37.10M
市盈率
—
EPS
-1.03
股息率
—
52 周区间
0.58 – 2.25
成交量
488.42K
Beta
-0.48
目标价
8.25
52W 低 0.5852W 高 2.25
价格走势
公司简介
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company’s pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and i...